Your browser doesn't support javascript.
loading
Atezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket Study.
Friedman, Claire F; Hainsworth, John D; Kurzrock, Razelle; Spigel, David R; Burris, Howard A; Sweeney, Christopher J; Meric-Bernstam, Funda; Wang, Yong; Levy, Jonathan; Grindheim, Jessica; Shames, David S; Schulze, Katja; Patel, Arisha; Swanton, Charles.
Affiliation
  • Friedman CF; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hainsworth JD; Weill Medical College at Cornell University, New York, New York.
  • Kurzrock R; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Spigel DR; Tennessee Oncology, PLLC, Nashville, Tennessee.
  • Burris HA; Moores Cancer Center, UC San Diego, San Diego, California.
  • Sweeney CJ; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Meric-Bernstam F; Tennessee Oncology, PLLC, Nashville, Tennessee.
  • Wang Y; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Levy J; Tennessee Oncology, PLLC, Nashville, Tennessee.
  • Grindheim J; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Shames DS; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Schulze K; Genentech, Inc., South San Francisco, California.
  • Patel A; Genentech, Inc., South San Francisco, California.
  • Swanton C; Genentech, Inc., South San Francisco, California.
Cancer Discov ; 12(3): 654-669, 2022 03 01.
Article in En | MEDLINE | ID: mdl-34876409
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: Cancer Discov Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / Neoplasms Type of study: Clinical_trials Limits: Humans Language: En Journal: Cancer Discov Year: 2022 Document type: Article Country of publication: United States